Amylin inhibits bone resorption while the calcitonin receptor controls bone formation in vivo
Open accessThe DOI matches its Crossref record; 25 of the 25 references it cites were found in a registry or an index.
Abstract
Amylin is a member of the calcitonin family of hormones cosecreted with insulin by pancreatic β cells. Cell culture assays suggest that amylin could affect bone formation and bone resorption, this latter function after its binding to the calcitonin receptor (CALCR). Here we show that Amylin inactivation leads to a low bone mass due to an increase in bone resorption, whereas bone formation is unaffected. In vitro, amylin inhibits fusion of mononucleated osteoclast precursors into multinucleated osteoclasts in an ERK1/2-dependent manner. Although Amylin +/− mice like Amylin-deficient mice display a low bone mass phenotype and increased bone resorption, Calcr +/− mice display a high bone mass due to an increase in bone formation. Moreover, compound heterozygote mice for Calcr and Amylin inactivation displayed bone abnormalities observed in both Calcr +/− and Amylin +/− mice, thereby ruling out that amylin uses CALCR to inhibit osteoclastogenesis in vivo. Thus, amylin is a physiological regulator of bone resorption that acts through an unidentified receptor.
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Figures




Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Claims other papers make about this one
Each is checked against this paper’s own text: does it say what the citing paper says it does?
The cited source says what the claim attributes to it.
In the citing paper
“A later study found that the activity of amylin to inhibit cell fusion required the activation of the extracellular signal-regulated protein kinase 1/2 (ERK1/2) in osteoclast precursors (58).”
From The Activity of Peptides of the Calcitonin Family in Bone (2019) · cites this paper as [58]
The cited source says what the claim attributes to it.
In the citing paper
“Amylin deficiency had no effect on the regulation of food intake, body weight, or glucose metabolism in this experimental model.”
From The Activity of Peptides of the Calcitonin Family in Bone (2019) · cites this paper as [58]
The cited source says what the claim attributes to it.
In the citing paper
“The amylin KO mice had an increased number of osteoclasts and an increase in degradation products of collagen in the urine, suggesting that the osteoporotic phenotype was a result of accelerated bone resorption (58).”
From The Activity of Peptides of the Calcitonin Family in Bone (2019) · cites this paper as [58]
The cited source says what the claim attributes to it.
In the citing paper
“Similar to the phenotype described for the Calca-deficient mice (97), Calcr ϩ/Ϫ mice had high bone mass caused by increased bone formation without changes in bone resorption (58).”
From The Activity of Peptides of the Calcitonin Family in Bone (2019) · cites this paper as [58]
The cited source says what the claim attributes to it.
In the citing paper
“At the age of 24 wk, both male and female amylin KO mice were osteoporotic with vertebral bone volume over tissue volume (BV/TV) ~50% lower than that of WT and trabecular and cortical bone thickness reduced.”
From The Activity of Peptides of the Calcitonin Family in Bone (2019) · cites this paper as [58]
3 more claims about this paper
Create a free account to see every claim other papers make about this one.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Osteoclast differentiation and activation
Boyle, W. J., Simonet, W. S., & Lacey, D. L. (2003) · Nature · doi:10.1038/nature01658 · Cited by 6,670 · cited 2×
“…studies have identified transcription factors, growth factors and their receptors, hormones and intracellular signaling molecules that affect one or the other arm of bone remodeling at the level of cell differentiation, proliferation, or function (Boyle et al., 2003; Teitelbaum and Ross, 2003).”
BackgroundParfitt, A. M., Drezner, M. K., Glorieux, F. H., Kanis, J. A., Malluche, H., Meunier, P. J., Ott, S. M., & Recker, R. R. (1987) · Journal of Bone and Mineral Research · doi:10.1002/jbmr.5650020617 · Cited by 5,016 · cited 1×
“This was surprising as the calcitonin receptor (CALCR) is expressed on osteoclasts but not on osteoblasts ( Nicholson et al., 1986; Lee et al., 1995).”
BackgroundBone Histomorphometry : Standardization of Nomenclature, Symbols, and Units
PARFITT, A. M., Drezner, M. K., Glorieux, F. H., Kanis, J. А., Malluche, H. H., Meunier, P. J., Ott, S. M., & Recker, R. R. (1987) · Journal of Bone and Mineral Research · Cited by 3,258
Genetic regulation of osteoclast development and function
Teitelbaum, S. L., & Ross, F. P. (2003) · Nature Reviews Genetics · doi:10.1038/nrg1122 · Cited by 1,701 · cited 1×
“These latter studies have identified transcription factors, growth factors and their receptors, hormones and intracellular signaling molecules that affect one or the other arm of bone remodeling at the level of cell differentiation, proliferation, or function (Boyle et al., 2003; Teitelbaum and Ross, 2003).”
BackgroundEffects of Diabetes Mellitus on Bone Mass in Juvenile and Adult-Onset Diabetes
Levin, M. E., Boisseau, V. C., & Avioli, L. V. (1976) · New England Journal of Medicine · doi:10.1056/nejm197601292940502 · Cited by 519 · cited 1×
“Indeed, the predominant expression of amylin in pancreatic cells support the hypothesis that the low bone mass phenotype observed in Type I diabetes patients (Levin et al., 1976) may be secondary, at least in part, to the absence of amylin secretion in these patients.”
BackgroundChristopoulos, G., Perry, K. J., Morfis, M., Tilakaratne, N., Gao, Y., Fraser, N. J., Main, M. J., Foord, S. M., & Sexton, P. M. (1999) · Molecular Pharmacology · doi:10.1124/mol.56.1.235 · Cited by 486 · cited 2×
“, 1999, 2001); that amylin is able to bind in vitro to CALCR has raised the hypothesis that it may be a physiological ligand of CALCR on osteoclasts (Christopoulos et al., 1999).”
BackgroundNicholson, G. C., Moseley, J. M., Sexton, P. M., Mendelsohn, F. A., & Martin, T. J. (1986) · Journal of Clinical Investigation · doi:10.1172/jci112584 · Cited by 454 · cited 2×
“This was surprising as the calcitonin receptor (CALCR) is expressed on osteoclasts but not on osteoblasts (Nicholson et al., 1986; Lee et al., 1995).”
BackgroundEvidence of Cosecretion of Islet Amyloid Polypeptide and Insulin by β-Cells
Kahn, S. E., D'Alessio, D. A., Schwartz, M. W., Fujimoto, W. Y., Ensinck, J. W., Taborsky, G. J., & Porte, D. (1990) · Diabetes · doi:10.2337/diab.39.5.634 · Cited by 454 · cited 2×
“Amylin, the focus of this paper, was identified as a protein present in pancreatic cells that is cosecreted with insulin after food ingestion (Westermark et al., 1987; Kahn et al., 1990).”
BackgroundRoh, J., Chang, C. L., Bhalla, A., Klein, C., & Hsu, S. Y. T. (2004) · Journal of Biological Chemistry · doi:10.1074/jbc.m305332200 · Cited by 443
Amylin, Calcitonin Gene-Related Peptide, Calcitonin, and Adrenomedullin: A Peptide Superfamily
Wimalawansa, S. J. (1997) · Critical Reviews™ in Neurobiology · doi:10.1615/critrevneurobiol.v11.i2-3.40 · Cited by 424 · cited 2×
“Calcitonin is the founding member of a small family of polypeptide hormones that comprises of CGRP, adrenomedullin, intermedin, CALCR stimulating hormone, and amylin or islet amyloid polypeptide (Wimalawansa, 1997; Katafuchi et al., 2003; Roh et al., 2003).”
Background
Research works printed but not linked: 4
- 1998, Am. J. Physiol., 275, E694
- 1995, Endocrinology., 136, 4572, 10.1210/endo.136.10.7664679 · doi:10.1210/endo.136.10.7664679 · Paper page
- 1992, Endocrinology., 131, 1497, 10.1210/endo.131.3.1324163 · doi:10.1210/endo.131.3.1324163 · Paper page
- 1987, Am. J. Pathol., 127, 414
Cited by
Skeletal remodeling in health and disease
Zaidi, M. (2007) · Nature Medicine · doi:10.1038/nm1593 · Cited by 1,069
“By contrast, mice deficient in amylin, another related peptide from the calcitonin gene superfamily, show osteopeni”
BackgroundOsteoclast-derived activity in the coupling of bone formation to resorption
Martin, T. J., & Sims, N. A. (2005) · Trends in Molecular Medicine · doi:10.1016/j.molmed.2004.12.004 · Cited by 659
Maternal Mineral and Bone Metabolism During Pregnancy, Lactation, and Post-Weaning Recovery
Kovacs, C. S. (2016) · Physiological Reviews · doi:10.1152/physrev.00027.2015 · Cited by 544
Correlation of Obesity and Osteoporosis: Effect of Fat Mass on the Determination of Osteoporosis
Zhao, L.-J., Jiang, H., Papasian, C. J., Maulik, D., Drees, B., Hamilton, J., & Deng, H.-W. (2008) · Journal of Bone and Mineral Research · doi:10.1359/jbmr.070813 · Cited by 528
“reduce osteoclast development and thus inhibit bone resorption.((157)) In addition, amylin stimulates the prolifera-”
BackgroundOsteoporosis in Patients With Diabetes Mellitus
Hofbauer, L. C., Brueck, C. C., Singh, S. K., & Dobnig, H. (2007) · Journal of Bone and Mineral Research · doi:10.1359/jbmr.070510 · Cited by 503
“The phenotype of amylin-deficient mice is characterized by osteopenia and enhanced bone resorption, and amylin was found to inhibit osteoclastogenesis in vitro.((34))”
BackgroundAmylin: Pharmacology, Physiology, and Clinical Potential
Hay, D. L., Chen, S., Lutz, T. A., Parkes, D. G., & Roth, J. D. (2015) · Pharmacological Reviews · doi:10.1124/pr.115.010629 · Cited by 400
“Deletion of exons 6 and 7 of the calcitonin receptor gene calcr results in no viable offspring (Dacquin et al., 2004).”
BackgroundBone, sweet bone—osteoporotic fractures in diabetes mellitus
Hamann, C., Kirschner, S., Günther, K.-P., & Hofbauer, L. C. (2012) · Nature Reviews Endocrinology · doi:10.1038/nrendo.2011.233 · Cited by 380
Hormones and Disorders of Mineral Metabolism
Bringhurst, F. R., Demay, M. B., & Kronenberg, H. M. (2011) · Williams Textbook of Endocrinology · doi:10.1016/b978-1-4377-0324-5.00028-6 · Cited by 298
Kovacs, C. S. (2014) · Physiological Reviews · doi:10.1152/physrev.00014.2014 · Cited by 258
“In contrast, ablation of the calcitonin receptor (Ctr) causes embryonic lethality at mid-gestation for unknown reasons (134, 361).”
BackgroundType 2 diabetes and the skeleton: new insights into sweet bones
Shanbhogue, V. V., Mitchell, D. M., Rosen, C. J., & Bouxsein, M. L. (2016) · The Lancet Diabetes & Endocrinology · doi:10.1016/s2213-8587(15)00283-1 · Cited by 237
Henriksen, K., Bollerslev, J., Everts, V., & Karsdal, M. A. (2011) · Endocrine Reviews · doi:10.1210/er.2010-0006 · Cited by 230
Hayden, M. R., Tyagi, S. C., Kolb, L., Sowers, J. R., & Khanna, R. (2005) · Cardiovascular Diabetology · doi:10.1186/1475-2840-4-4 · Cited by 203
“Amylin may be considered to be the fraternal twin of insulin and has recently been shown to be a physiologic regulator of bone remodeling through favoring bone formation, while inhibiting bone resorption and thus is osteogenic [23] (table 3).”
Keller, J., Catala-Lehnen, P., Huebner, A. K., Jeschke, A., Heckt, T., Lueth, A., Krause, M., Koehne, T., Albers, J., Schulze, J., et al. (2014) · Nature Communications · doi:10.1038/ncomms6215 · Cited by 211
The Impact of Diabetes and Diabetes Medications on Bone Health
Gilbert, M. P., & Pratley, R. E. (2015) · Endocrine Reviews · doi:10.1210/er.2012-1042 · Cited by 209
“ficiency has been shown to lead to bone loss in mice, and treatment with amylin can partially reverse osteopenia in ovariectomized rats (127, 128).”
Bone remodelling: its local regulation and the emergence of bone fragility
Martin, T. J., & Seeman, E. (2008) · Best Practice & Research Clinical Endocrinology & Metabolism · doi:10.1016/j.beem.2008.07.006 · Cited by 203
The insulin secretory granule as a signaling hub
Suckale, J., & Solimena, M. (2010) · Trends in Endocrinology & Metabolism · doi:10.1016/j.tem.2010.06.003 · Cited by 201
The role of peptides and receptors of the calcitonin family in the regulation of bone metabolism
Naot, D., & Cornish, J. (2008) · Bone · doi:10.1016/j.bone.2008.07.003 · Cited by 182
“CTR haploinsufficiency was produced in heterozygous CTR+/− mice, where the expression of CTR in osteoclasts was half that of the wildtype [43].”
BackgroundMembrane interaction of islet amyloid polypeptide
Jayasinghe, S. A., & Langen, R. (2007) · Biochimica et Biophysica Acta (BBA) - Biomembranes · doi:10.1016/j.bbamem.2007.01.022 · Cited by 176
Glucose-dependent insulinotropic polypeptide receptor knockout mice have altered bone turnover
Xie, D., Cheng, H., Hamrick, M., Zhong, Q., Ding, K.-H., Correa, D., Williams, S., Mulloy, A., Bollag, W., Bollag, R. J., et al. (2005) · Bone · doi:10.1016/j.bone.2005.06.021 · Cited by 171
“Amylin, co-secreted with insulin from βcells in response to meal ingestion, also influences calcium homeostasis by inhibiting bone resorption, thereby reducing serum calcium and increasing bone mass [9,11,14].”
BackgroundCurrent advances in regulation of bone homeostasis
Al‐Bari, M. A. A., & Mamun, A. A. (2020) · FASEB BioAdvances · doi:10.1096/fba.2020-00058 · Cited by 162
Chien, K. R., & Karsenty, G. (2005) · Cell · doi:10.1016/j.cell.2005.02.006 · Cited by 150
Self-citationThe Activity of Peptides of the Calcitonin Family in Bone
Naot, D., Musson, D. S., & Cornish, J. (2019) · Physiological Reviews · doi:10.1152/physrev.00066.2017 · Cited by 141
“sion of CTR in osteoclasts was half of that found in the WT, and thus, these animals were used as a model of Calcr haploinsufficiency (58).”
BackgroundMethodResultInfluentialControl of energy homeostasis by amylin
Lutz, T. A. (2011) · Cellular and Molecular Life Sciences · doi:10.1007/s00018-011-0905-1 · Cited by 148
Molecular Genetic Studies of Gene Identification for Osteoporosis: A 2004 Update
Liu, Y., Shen, H., Xiao, P., Xiong, D.-H., Li, L.-H., Recker, R. R., & Deng, H. (2006) · Journal of Bone and Mineral Research · doi:10.1359/jbmr.051002 · Cited by 144
Neuronal signaling and the regulation of bone remodeling
Elefteriou, F. (2005) · Cellular and Molecular Life Sciences · doi:10.1007/s00018-005-5175-3 · Cited by 144
Yamaguchi, M., Watanabe, Y., Ohtani, T., Uezumi, A., Mikami, N., Nakamura, M., Sato, T., Ikawa, M., Hoshino, M., Tsuchida, K., et al. (2015) · Cell Reports · doi:10.1016/j.celrep.2015.08.083 · Cited by 126
Wakkach, A., Mansour, A., Dacquin, R., Coste, E., Jurdic, P., Carle, G. F., & Blin-Wakkach, C. (2008) · Blood · doi:10.1182/blood-2008-01-132787 · Cited by 118
Self-citationAdiponectin Inhibits Osteoclastogenesis and Bone Resorption via APPL1-mediated Suppression of Akt1
Tu, Q., Zhang, J., Dong, L. Q., Saunders, E., Luo, E., Tang, J., & Chen, J. (2011) · Journal of Biological Chemistry · doi:10.1074/jbc.m110.152405 · Cited by 122
Amylin Modulates the Mesolimbic Dopamine System to Control Energy Balance
Mietlicki‐Baase, E. G., Reiner, D. J., Cone, J. J., Olivos, D. R., McGrath, L. E., Zimmer, D. J., Roitman, M. F., & Hayes, M. R. (2014) · Neuropsychopharmacology · doi:10.1038/npp.2014.180 · Cited by 122
Gooi, J. H., Pompolo, S., Karsdal, M. A., Kulkarni, N. H., Kalajzic, I., McAhren, S. H. M., Han, B., Onyia, J. E., Ho, P. W. M., Gillespie, M. T., et al. (2010) · Bone · doi:10.1016/j.bone.2010.02.018 · Cited by 117
“These observations indicate an inhibitory effect of calcitonin on bone formation, as in the other genetic studies [68, 71, 72, 74].”
BackgroundResultEmerging Therapies Mimicking the Effects of Amylin and Glucagon-Like Peptide 1
Riddle, M. C., & Drucker, D. J. (2006) · Diabetes Care · doi:10.2337/diacare.29.02.06.dc05-1267 · Cited by 109
“Amylin also exerts an inhibitory effect on bone resorption, and amylin / mice exhibit reduced bone mass, increased numbers of osteoclasts, and increased rates of bone resorption (92).”
BackgroundMabilleau, G., Mieczkowska, A., Irwin, N., Flatt, P. R., & Chappard, D. (2013) · Journal of Endocrinology · doi:10.1530/joe-13-0146 · Cited by 106
Diabetes pharmacotherapy and effects on the musculoskeletal system
Kalaitzoglou, E., Fowlkes, J. L., Popescu, I., & Thrailkill, K. M. (2019) · Diabetes/Metabolism Research and Reviews · doi:10.1002/dmrr.3100 · Cited by 100
“As would be consistent with these anti‐resorption effects, mice with targeted deletion of the amylin gene exhibit low bone mass, attributable to chronically unrestricted bone resorption.(421,422) Additionally, daily amylin treatment has been shown to inhibit ovariectomy‐induced trabecular bone loss in rats, again by i…”
BackgroundBrommage, R., Liu, J., Hansen, G. M., Kirkpatrick, L. L., Potter, D. G., Sands, A. T., Zambrowicz, B., Powell, D. R., & Vogel, P. (2014) · Bone Research · doi:10.1038/boneres.2014.34 · Cited by 100
The role of GPCRs in bone diseases and dysfunctions
Luo, J., Sun, P., Siwko, S., Liu, M., & Xiao, J. (2019) · Bone Research · doi:10.1038/s41413-019-0059-6 · Cited by 99
Calcitonin: Physiology or fantasy?
Davey, R. A., & Findlay, D. M. (2013) · Journal of Bone and Mineral Research · doi:10.1002/jbmr.1869 · Cited by 101
“exhibited increased vertebral trabecular bone volume as a result of increased bone formation rate, whereas bone resorption was unaffected.((38)) Further investigation into the role of the CTR in bone formation in these mice was limited by the fact that homozygous deletion of the CTR resulted in embryonic lethality,((3…”
BackgroundInfluentialSelf-citationThe critical interplay between bone resorbing and bone forming cells
Lerner, U. H., Kindstedt, E., & Lundberg, P. (2019) · Journal Of Clinical Periodontology · doi:10.1111/jcpe.13051 · Cited by 112
Integration of Satiety Signals by the Central Nervous System
Chambers, A. P., Sandoval, D. A., & Seeley, R. J. (2013) · Current Biology · doi:10.1016/j.cub.2013.03.020 · Cited by 90
“Despite the above pharmacological evidence, amylin knockout mice have normal food intake and growth curves compared with wild-type mice [71,72].”
Asthana, S., Mallick, B., Alexandrescu, A. T., & Jha, S. (2018) · Biochimica et Biophysica Acta (BBA) - Biomembranes · doi:10.1016/j.bbamem.2018.02.020 · Cited by 104
Lerner, U. H., & Persson, E. (2008) · PubMed · Cited by 112
Bone and mineral metabolism in patients undergoing Roux-en-Y gastric bypass
Hage, M. P., & Fuleihan, G. E. (2013) · Osteoporosis International · doi:10.1007/s00198-013-2480-9 · Cited by 104
“Amylin-deficient mice displayed a low bone mass phenotype secondary to an increase in bone resorption [52].”
Brainstem mechanisms of amylin-induced anorexia
Potes, C. S., & Lutz, T. A. (2010) · Physiology & Behavior · doi:10.1016/j.physbeh.2010.03.001 · Cited by 100
“For this reason and because amylin has recently been demonstrated to stimulate ERK signaling in osteoclasts which carry specific amylin receptors [17,62], we hypothesized that”
BackgroundReview: The Diabetic Bone: A Cellular and Molecular Perspective
Blakytny, R., Spraul, M., & Jude, E. B. (2011) · The International Journal of Lower Extremity Wounds · doi:10.1177/1534734611400256 · Cited by 103
Amylin receptor blockade stimulates food intake in rats
Reidelberger, R. D., Haver, A. C., Arnelo, U., Smith, D. D., Schaffert, C. S., & Permert, J. (2004) · American Journal of Physiology-Regulatory, Integrative and Comparative Physiology · doi:10.1152/ajpregu.00213.2004 · Cited by 91
Thiazolidinedione‐induced skeletal fragility – mechanisms and implications
Grey, A. (2009) · Diabetes, Obesity and Metabolism · doi:10.1111/j.1463-1326.2008.00931.x · Cited by 90
Calcitonin Receptor Plays a Physiological Role to Protect Against Hypercalcemia in Mice
Davey, R. A., Turner, A. G., McManus, J. F., Chiu, W. M., Tjahyono, F., Moore, A. J., Atkins, G. J., Anderson, P. H., Ma, C., Glatt, V., et al. (2008) · Journal of Bone and Mineral Research · doi:10.1359/jbmr.080310 · Cited by 87
“of the CTR in mice results in CTR haploinsufficiency with CTR expression decreased by 50%.((8)) Despite the potent”
BackgroundMethodResultInfluentialSelf-citationPotential Role of Pancreatic and Enteric Hormones in Regulating Bone Turnover
Clowes, J. A., Khosla, S., & Eastell, R. (2005) · Journal of Bone and Mineral Research · doi:10.1359/jbmr.050524 · Cited by 87
“An amylin knockout model resulted in decreased BMD,((54)) an effect that seemed to be mediated through an inhibition of osteoclastogenesis with no apparent effect on osteoblast differentiation or function.”
BackgroundInfluentialCalcitonin Deficiency in Mice Progressively Results in High Bone Turnover
Huebner, A. K., Schinke, T., Priemel, M., Schilling, S., Schilling, A. F., Emeson, R. B., Rueger, J. M., & Amling, M. (2006) · Journal of Bone and Mineral Research · doi:10.1359/jbmr.060820 · Cited by 81
“This is especially needed, because the complete deficiency of the CT receptor in mice causes embryonic lethality.((36)) Interestingly, mice lacking only one allele of the CT receptor are viable and display a high bone mass phenotype caused by an increased bone formation.”
BackgroundResultEffects of Anorexia Nervosa on Bone Metabolism
Fazeli, P. K., & Klibanski, A. (2018) · Endocrine Reviews · doi:10.1210/er.2018-00063 · Cited by 87
Control of Bone Resorption by Semaphorin 4D Is Dependent on Ovarian Function
Dacquin, R., Domenget, C., Kumanogoh, A., Kikutani, H., Jurdic, P., & Machuca-Gayet, I. (2011) · PLoS ONE · doi:10.1371/journal.pone.0026627 · Cited by 73
“Mice were injected with 100 ml of a 5 mg/ml of a calcein solution, 6 and 2 days before sacrifice and were processed for plastic embedding, as previously described [33].”
MethodSelf-citationCalcitonin and Bone Physiology: In Vitro, In Vivo, and Clinical Investigations
Xie, J., Guo, J., Kanwal, Z., Wu, M., Lv, X., Ibrahim, N. A., Li, P., Buabeid, M. A., Arafa, E. A., & Sun, Q. (2020) · International Journal of Endocrinology · doi:10.1155/2020/3236828 · Cited by 83
“However, osteoclasts number collagen degradation products were higher in the amylin KO mice, showing that a swift bone resorption resulted in the osteoporotic phenotype [116].”
BackgroundInfluentialCalcitonin receptor signaling in the medial preoptic area enables risk-taking maternal care
Yoshihara, C., Tokita, K., Maruyama, T., Kaneko, M., Tsuneoka, Y., Fukumitsu, K., Miyazawa, E., Shinozuka, K., Huang, A. J. Y., Nishimori, K., et al. (2021) · Cell Reports · doi:10.1016/j.celrep.2021.109204 · Cited by 81
Osteoclastic differentiation and function regulated by old and new pathways
Blair, H. C., & Zaidi, M. (2006) · Reviews in Endocrine and Metabolic Disorders · doi:10.1007/s11154-006-9010-4 · Cited by 82
“Further, in mouse models, deletion of calcitonin [39] or its receptor [20], do not reduce bone mass as expected.”
BackgroundThe role of calcitonin and α-calcitonin gene-related peptide in bone formation
Huebner, A. K., Keller, J., Catala-Lehnen, P., Perkovic, S., Streichert, T., Emeson, R. B., Amling, M., & Schinke, T. (2008) · Archives of Biochemistry and Biophysics · doi:10.1016/j.abb.2008.02.013 · Cited by 73
Novel Genetic Models of Osteoporosis by Overexpression of Human RANKL in Transgenic Mice
Rinotas, V. E., Niti, A., Dacquin, R., Bonnet, N., Stolina, M., Han, C.-Y. E., Kostenuik, P. J., Jurdic, P., Ferrari, S., & Douni, E. K. (2013) · Journal of Bone and Mineral Research · doi:10.1002/jbmr.2112 · Cited by 77
“For assessment of bone formation, mice were injected with 100mL calcein (5mg/mL), 6 and 2 days before euthanization, and undecalcified bones were embedded in methyl methacrylate according to standard double‐labeling protocols.((22)) Ectopic calcification in soft tissues was detected after staining with 2% Alizarin Red…”
MethodSelf-citationFudge, N. J., & Kovács, C. S. (2004) · BMC Physiology · doi:10.1186/1472-6793-4-5 · Cited by 68
“Mice that are heterozygous for loss of the calcitonin receptor also have a phenotype of increased bone mass as adults [20].”
BackgroundBishoyi, A. K., Roham, P. H., Rachineni, K., Save, S. N., Hazari, M. A., Sharma, S., & Kumar, A. (2020) · Biological Chemistry · doi:10.1515/hsz-2020-0174 · Cited by 68
Walsh, J., & Henriksen, D. B. (2010) · Archives of Biochemistry and Biophysics · doi:10.1016/j.abb.2010.06.020 · Cited by 71
Ramanadham, S., Yarasheski, K. E., Silva, M. J., Wohltmann, M., Novack, D. V., Christiansen, B., Tu, X., Zhang, S., Lei, X., & TURK, J. W. (2008) · American Journal Of Pathology · doi:10.2353/ajpath.2008.070756 · Cited by 73
Granholm, S., Lundberg, P., & Lerner, U. H. (2007) · Journal of Endocrinology · doi:10.1677/joe-07-0338 · Cited by 63
“In contrast, inactivationofthe amylingeneleadstodecreased bonemassdue toincreased boneresorptionwhichindicates thatamylinmaybe a more important regulator of physiological bone resorption than CT (Dacquin et al .”
Muff, R., Born, W., Lutz, T. A., & Fischer, J. A. (2004) · Peptides · doi:10.1016/j.peptides.2004.08.007 · Cited by 62
Bone metabolism in the fetus and neonate
Kovács, C. S. (2013) · Pediatric Nephrology · doi:10.1007/s00467-013-2461-4 · Cited by 62
“Human placenta expresses PTH1R, and treatment with PTH [1–34] increases Ca accumulation within vesicles constructed from syncytiotrophoblast basal membranes [28].”
BackgroundIntegrative Population and Physiological Genomics Reveals Mechanisms of Adaptation in Killifish
Brennan, R. S., Healy, T. M., Bryant, H. J., La, V. E., Schulte, P. M., & Whitehead, A. (2018) · Molecular Biology and Evolution · doi:10.1093/molbev/msy154 · Cited by 66
Cytokines and Hormones That Contribute to the Positive Association between Fat and Bone
Naot, D., & Cornish, J. (2014) · Frontiers in Endocrinology · doi:10.3389/fendo.2014.00070 · Cited by 57
Patterns, Mechanisms and Genetics of Speciation in Reptiles and Amphibians
Valero, K. C. W., Marshall, J. C., Bastiaans, E., Caccone, A., Camargo, A., Morando, M. M., Niemiller, M. L., Pabijan, M., Russello, M. A., Sinervo, B., et al. (2019) · Genes · doi:10.3390/genes10090646 · Cited by 64
“This gene is known to regulate bone mineral density in humans [397,398], and is involved in preferred temperature selection and body temperature regulation across the animal kingdom [399].”
BackgroundCalcitonin is involved in cartilage homeostasis: Is calcitonin a treatment for OA?
Karsdal, M. A., Tankó, L. B., Riis, B. J., Søndergaard, B. C., Henriksen, K., Altman, R. D., Qvist, P., & Christiansen, C. (2006) · Osteoarthritis and Cartilage · doi:10.1016/j.joca.2006.03.014 · Cited by 64
Fukumitsu, K., Kaneko, M., Maruyama, T., Yoshihara, C., Huang, A. J. Y., McHugh, T. J., Itohara, S., Tanaka, M., & Kuroda, K. O. (2022) · Nature Communications · doi:10.1038/s41467-022-28131-z · Cited by 57
Granholm, S., Lundberg, P., & Lerner, U. H. (2008) · Journal of Cellular Biochemistry · doi:10.1002/jcb.21674 · Cited by 54
“…in the present study, that AMY signaling can be observed in cells lacking CTR, is in line with the observation that the decreased bone mass and enhanced bone resorption seen in Amy-deficient mice can also be seen in compound heterozygote mice for Ctr and Amy inactivation [Dacquin et al., 2004].”
ResultPotes, C. S., Boyle, C. N., Wookey, P. J., Riediger, T., & Lutz, T. A. (2012) · American Journal of Physiology-Regulatory, Integrative and Comparative Physiology · doi:10.1152/ajpregu.00380.2011 · Cited by 51
Zhang, M., Ren, B., Liu, Y., Liang, G., Sun, Y. P., Xu, L., & Zheng, J. (2017) · ACS Chemical Neuroscience · doi:10.1021/acschemneuro.7b00160 · Cited by 52
Mabilleau, G., Perrot, R., Mieczkowska, A., Boni, S., Flatt, P. R., Irwin, N., & Chappard, D. (2016) · Bone · doi:10.1016/j.bone.2016.07.014 · Cited by 51
McDonald, K. R., Fudge, N. J., Woodrow, J. P., Friel, J. K., Hoff, A. O., Gagel, R. F., & Kovacs, C. S. (2004) · American Journal of Physiology-Endocrinology and Metabolism · doi:10.1152/ajpendo.00023.2004 · Cited by 51
“(12) that heterozygous ablation of the calcitonin receptor also leads to a higher bone mass.”
BackgroundMoayyeri, A., Luben, R., Wareham, N. J., & Khaw, K. (2011) · Journal of Internal Medicine · doi:10.1111/j.1365-2796.2011.02443.x · Cited by 53
Diabetes Drug Effects on the Skeleton
Chandran, M. (2016) · Calcified Tissue International · doi:10.1007/s00223-016-0203-x · Cited by 48
Farmahin, R., Crump, D., O’Brien, J. M., Jones, S. P., & Kennedy, S. W. (2016) · Biochemical Pharmacology · doi:10.1016/j.bcp.2016.06.005 · Cited by 47
Lindfors, P. H., Lindahl, M., Rossi, J., Saarma, M., & Airaksinen, M. S. (2006) · Endocrinology · doi:10.1210/en.2005-1620 · Cited by 50
“Calcitonin as well as calcitonin receptor-deficient mice display a greater mineral apposition and bone formation rate compared with their WT littermates (18).”
BackgroundKadmiel, M., Fritz-Six, K., Pacharne, S., Richards, G. O., Li, M., Skerry, T. M., & Caron, K. M. (2011) · Molecular Endocrinology · doi:10.1210/me.2010-0400 · Cited by 44
Lee, H.-J., Kim, S.-Y., Kim, G. S., Hwang, J. Y., Kim, Y.-J., Jeong, B., Kim, T.-H., Park, E. K., Lee, S. H., Kim, H.-L., et al. (2009) · Osteoporosis International · doi:10.1007/s00198-009-1106-8 · Cited by 44
“The insertminus CTR isoform is expressed in essentially all human tissues known to express CTR and this variant CALCR gene is embryonically lethal in knockout mice, although the mechanism of this effect is not understood [21].”
BackgroundChia, L. Y., Walsh, N. C., Martin, T. J., & Sims, N. A. (2015) · Bone · doi:10.1016/j.bone.2014.11.005 · Cited by 42
“Calcitonin stimulates expression of sclerostin in young rats and mice [28], and this may mediate a role for calcitonin in inhibiting bone formation, indicated by studies in genetically altered mice [53,54].”
BackgroundReduced amylin levels are associated with low bone mineral density in women with anorexia nervosa
Wojcik, M. H., Meenaghan, E., Lawson, E. A., Misra, M., Klibanski, A., & Miller, K. K. (2010) · Bone · doi:10.1016/j.bone.2009.11.014 · Cited by 39
“Indeed, amylin-deficient mice have a low bone mass phenotype [19] and decreased trabecular volume and number [21].”
Pros and cons of fatty acids in bone biology
Wauquier, F., Léotoing, L., Philippe, C., Spilmont, M., Coxam, V., & Wittrant, Y. (2015) · Progress in Lipid Research · doi:10.1016/j.plipres.2015.03.001 · Cited by 46
Turner, A. G., Tjahyono, F., Chiu, W. S. M., Skinner, J., Sawyer, R., Moore, A. J., Morris, H. A., Findlay, D. M., Zajac, J. D., & Davey, R. A. (2011) · Bone · doi:10.1016/j.bone.2010.09.013 · Cited by 39
Self-citationSeck, T., Pellegrini, M., Florea, A. M., Grignoux, V., Baron, R., Mierke, D. F., & Horne, W. C. (2005) · Molecular Endocrinology · doi:10.1210/me.2004-0472 · Cited by 38
“Knockout of the CTR gene in mice is embryonic lethal by a yet unidentified mechanism (7).”
BackgroundBlair, H. C., Zaidi, M., Huang, C. L.-H., & Sun, L. (2008) · Biological reviews/Biological reviews of the Cambridge Philosophical Society · doi:10.1111/j.1469-185x.2008.00048.x · Cited by 48
“Mice deficient in amylin, a related peptide to calcitonin, develop osteopenia, however (Dacquin et al., 2004; Datta et al., 1989).”
BackgroundLinking hIAPP misfolding and aggregation with type 2 diabetes mellitus: a structural perspective
Hassan, S., White, K., & Terry, C. (2022) · Bioscience Reports · doi:10.1042/bsr20211297 · Cited by 38
Gastrointestinal peptides and bone health
Wong, I. P. L., Baldock, P. A. J., & Herzog, H. (2010) · Current Opinion in Endocrinology Diabetes and Obesity · doi:10.1097/med.0b013e3283344a05 · Cited by 39
Amylin and the Integrated Control of Nutrient Influx
Young, A. J. (2005) · Advances in pharmacology · doi:10.1016/s1054-3589(05)52004-0 · Cited by 35
Mancini, L., Paul-Clark, M. J., Rosignoli, G., Hannon, R., Martin, J. E., Macintyre, I., & Perretti, M. (2007) · The American Journal of Pathology · doi:10.2353/ajpath.2007.060830 · Cited by 32
“However, the relationship of CT on osteoblast function is complex and may be bidirectional because CT receptor heterozygous knockout mice show an increase in bone formation.(32) Figure 7.”
BackgroundAmylin: From Mode of Action to Future Clinical Potential in Diabetes and Obesity
Volčanšek, Š., Koceva, A., Jensterle, M., Janež, A., & Muzurović, E. M. (2025) · Diabetes Therapy · doi:10.1007/s13300-025-01733-8 · Cited by 35
“Amylin is a modulator of bone remodeling as rodent studies show that it inhibits bone resorption [85–87], and may additionally stimulate bone formation [86, 87].”
Amylin in the Periphery II: An Updated Mini-Review
Wookey, P. J., Lutz, T. A., & Andrikopoulos, S. (2006) · The Scientific World JOURNAL · doi:10.1100/tsw.2006.263 · Cited by 32
“More recently, the analyses of amylin and CTR gene-deletion mouse models[62] have demonstrated that amylin is a factor that inhibits osteoclastogenesis and, therefore, reduces the rate of osteolysis.”
BackgroundResultLian, J. B., & Stein, G. S. (2006) · Elsevier eBooks · doi:10.1016/b978-012088562-6/50015-7 · Cited by 33
G Protein and Its signaling pathway in bone development and disease
Wu, M., Deng, L., Zhu, G., & Li, Y.-P. (2010) · Frontiers in bioscience · doi:10.2741/3656 · Cited by 42
“Amylin-/- mice (26) exhibit osteopenia due to increasing bone resorption, implicated by increasing osteoclast surface as demonstrated by trap staining.”
BackgroundInfluentialPark, B., Song, H. S., Kwon, J. E., Cho, S. M., Jang, S., Kim, M. Y., & Kang, S. C. (2017) · BMC Complementary and Alternative Medicine · doi:10.1186/s12906-017-2047-y · Cited by 31
“In addition, calcitonin receptor is expressed during osteoclast differentiation to osteoblast [42].”
BackgroundKinins and Neuro-osteogenic Factors
Lerner, U. H., Persson, E., & Lundberg, P. (2008) · Elsevier eBooks · doi:10.1016/b978-0-12-373884-4.00063-x · Cited by 31
Beyond resorption: osteoclasts as drivers of bone formation
Xiang, Q., Li, L., Ji, W., Gawlitta, D., Walboomers, X. F., & van den Beucken, J. J. J. P. (2024) · Cell Regeneration · doi:10.1186/s13619-024-00205-x · Cited by 33
“CTR, a G-protein-coupled receptor, regulates OC activity through its binding to calcitonin (Dacquin et al. 2004).”
BackgroundImpact of Dietary Aromatic Amino Acids on Osteoclastic Activity
Refaey, M. E., Zhong, Q., Ding, K., Shi, X., Xu, J., Bollag, W. B., Hill, W., Chutkan, N. B., Robbins, R., Nadeau, H. C. G., et al. (2014) · Calcified Tissue International · doi:10.1007/s00223-014-9878-z · Cited by 30
“The calcitonin receptor is expressed on osteoclasts but not osteoblasts and a specific marker for osteoclast differentiation [4].”
BackgroundSuppression of Bone Resorption by miR-141 in Aged Rhesus Monkeys
Yang, S., Zhang, W., Cai, M., Zhang, Y., Jin, F., Yan, S., Baloch, Z., Fang, Z., Xue, S., Tang, R., et al. (2018) · Journal of Bone and Mineral Research · doi:10.1002/jbmr.3479 · Cited by 29
“(32) Our results conclusively show that miR-141 functionally targets Calcr and EphA2, thereby controlling bone resorption.”
InfluentialFoll, C. L., & Lutz, T. A. (2020) · Comprehensive physiology · doi:10.1002/cphy.c190034 · Cited by 27
Granholm, S., Henning, P., & Lerner, U. H. (2011) · Journal of Cellular Biochemistry · doi:10.1002/jcb.23256 · Cited by 26
“Inhibitory effects on bone resorption and osteoclast formation have also been observed with CGRP and AMY, but not with ADM [Cornish et al., 2001; Dacquin et al., 2004; reviewed in Naot and Cornish, 2008].”
BackgroundInfluential
Metadata
- Authors
- Dacquin, R., Davey, R. A., Laplace, C., Levasseur, R., Morris, H. A., Goldring, S. R., Gebre-Medhin, S., Galson, D. L., Zajac, J. D., & Karsenty, G.
- Affiliations
- Baylor College of Medicine (US)
- The University of Melbourne (AU)
- Beth Israel Deaconess Medical Center (US)
- 1Department of Molecular and Human Genetics and Bone Disease Program of Texas, Baylor College of Medicine, Houston, TX 77030
- Hanson Institute (AU)
- 5Department of Clinical Genetics, Lund University Hospital, SE-221 85, Lund, Sweden
- Venue
- The Journal of Cell Biology
- Publisher
- Rockefeller University Press
- Published
- 2004-02-16
- Volume
- 164
- Issue
- 4
- Pages
- 509-514
- ISSN
- 0021-9525 (ISSN-L)
- 1540-8140
- PMC
- PMC2171986
- OpenAlex
- W2108642017
- Semantic Scholar
- 435fe5512c7d1d24870030fa33708cac75f27d06
- Cited by
- 206
- References
- 25
- Citations by year
- 2026: 7 · 2025: 3 · 2024: 4 · 2023: 6 · 2022: 2 · 2021: 8 · 2020: 7 · 2019: 11 · 2018: 8 · 2017: 5 · 2016: 7 · 2015: 10 · 2014: 12 · 2013: 7 · 2012: 11
- FWCI
- 5.10
- Type
- journal article
- Language
- en
- Open access
- bronze
- doi.org
- Locations
- The Journal of Cell Biology (publishedVersion)
- Europe PMC (PubMed Central) (publishedVersion, cc-by-nc-sa)
- PubMed Central (publishedVersion, cc-by-nc-sa)
- PubMed (publishedVersion)
- Adelaide Research & Scholarship (AR&S) (University of Adelaide) (submittedVersion)
- Minerva Access (University of Melbourne) (submittedVersion, cc-by-nc-sa)
- Lund University Publications (Lund University) (submittedVersion)
- Funders
- National Institute of Diabetes and Digestive and Kidney Diseases (R01DK058883, R01-DK58883)
- National Institute of Arthritis and Musculoskeletal and Skin Diseases (R01-AR45421, R01AR045421)
- Topics
- Life Sciences › Biochemistry, Genetics and Molecular Biology › Molecular Biology › Bone Metabolism and Diseases
- Health Sciences › Medicine › Orthopedics and Sports Medicine › Bone health and osteoporosis research
- Life Sciences › Biochemistry, Genetics and Molecular Biology › Biochemistry › Bone and Dental Protein Studies
- Keywords
- amylin, calcitonin receptor, bone resorption, bone formation, osteoclastogenesis, osteoclast precursors, ERK signaling, osteopenia, bone metabolism regulation
- MeSH terms
- Amyloid, Animals, Bone and Bones, Bone Resorption, Cell Differentiation, Mice, Inbred C57BL, Osteoclasts, Osteogenesis, Phenotype, Bone Density, Receptors, Calcitonin, Mice, Knockout, Mitogen-Activated Protein Kinases, Mice, Islet Amyloid Polypeptide
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.